Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmNEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (
NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician telemedicine users surveyed would like virtual care to remain a permanent part of their clinical practice. Among physicians surveyed, 84% highlighted telemedicine’s value in improving continuity of care for patients with chronic or complex conditions, and 96% emphasized its role as a complement to or, depending on the patient, a replacement for in-person care.
Doximity Announces Fiscal 2025 Second Quarter Financial Results
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024.
Doximity to Present at the Jefferies London Healthcare Conference
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced that Nate Gross, co-founder and chief strategy officer, and Anna Bryson, chief financial officer, will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 11:30 a.m. GMT/6:30 a.m. ET.
Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2024 after market close on November 7, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (
NYSEDOCS) breached their fiduciary duties to Doximity and its shareholders.
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmNEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (
NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
DOXIMITY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (
NYSEDOCS) breached their fiduciary duties to Doximity and its shareholders.
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmNEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (
NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
Doximity: The 'Facebook for Doctors' Surges After Earnings BeatDoximity Inc. (
NYSEDOCS) is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc.
DOXIMITY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Doximity, Inc. - DOCS
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (
NYSEDOCS).
Doximity Announces Fiscal 2025 First Quarter Financial Results
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024.
DOXIMITY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Doximity, Inc. - DOCS
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (
NYSEDOCS).
Doximity to Release Fiscal 2025 First Quarter Results on August 8, 2024
Doximity, Inc. (
NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmNEW YORK, June 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (
NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022 to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (
NYSEDOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
DOXIMITY 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (
NYSEDOCS), if they purchased or otherwise acquired the Company’s shares between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District California.
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (
NYSEDOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Doximity, Inc. (DOCS)
The Law Offices of Frank R. Cruz reminds investors of the upcoming June 17, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Doximity, Inc. (“Doximity” or the “Company”) (
NYSEDOCS) common stock between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”).
DOCS Investors Have Opportunity to Join Doximity, Inc. Securities Fraud Investigation with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or “the Company”) (
NYSEDOCS) for violations of the securities laws.
Rosen Law Firm Urges Doximity, Inc. (DOCS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (
NYSEDOCS) between February 9, 2022 and April 1, 2024. Doximity describes itself as a company that “operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals.”
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the FirmLOS ANGELES, June 11, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (
NYSEDOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
DOCS DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 17 Deadline in Securities Class Action – DOCSNEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (
NYSEDOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 17, 2024 lead plaintiff deadline.
